Symbol
| NQO2
| contributors: mct - updated : 07-03-2008
|
HGNC name
| NAD(P)H dehydrogenase, quinone 2
|
HGNC id
| 7856
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in ovarian carcinoma | |
Susceptibility
|
to schizophrenia |
Variant & Polymorphism
insertion/deletion
| deletion of the 29 base pair sequence in the promoter may confer susceptibility to a certain form of schizophrenia |
|
|
Candidate gene
Marker
Therapy target
| therapeutic target in ovarian carcinoma, because the addition of the nonbiogenic electron donor dihydronicotinamide riboside (NRH) selectively potentiates the bioactivation of the alkylating agent tretazicar | |
potential target of the quinoline antimalarial compounds |
| | |